In Brief: Dade International/Behring Diagnostics
This article was originally published in The Gray Sheet
Executive Summary
Dade International/Behring Diagnostics: Firms complete merger agreement to create $1.5 bil. worldwide diagnostics concern with 8,700 employees and manufacturing and marketing operations in 22 countries. Under terms of the deal, announced March 12 ("The Gray Sheet" March 17, p. 3), former Behring parent Hoechst AG retains a 32.5% stake in the combined entity, which is renamed Dade Behring...
You may also be interested in...
Dade Behring To Restructure $1.5 Bil. Debt, Become Public Firm
Diagnostics manufacturer Dade Behring hopes to emerge from its Aug. 1 Chapter 11 bankruptcy protection filing as a public company by October
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.